UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

慢性手部湿疹

Author
Michael P Sheehan, MD
Section Editor
Joseph Fowler, MD
Deputy Editor
Rosamaria Corona, MD, DSc
Translators
韩永智, 副主任医师

引言

手部湿疹或手部皮炎是一种累及手部皮肤的常见炎症性疾病[1]。慢性手部湿疹一词适用于持续超过3个月或者在12个月内复发2次或多次的湿疹[2]。典型临床表现包括发红、皮肤增厚、脱屑、水肿、起水疱、角化过度区域、开裂(皲裂)和糜烂。

手部湿疹是最常见的职业皮肤病，尤其是在暴露于“湿作业”的工作者中，例如医务人员、食物处理人员和美发人员。手部湿疹可以造成严重的经济后果，包括医疗成本，与活动不便、员工补偿和康复相关的成本，误工，以及失业[3]。严重手部湿疹会影响患者的心理社会功能和总体幸福感。

本专题将总结慢性手部湿疹的临床表现、诊断和治疗。急性掌跖湿疹、刺激性接触性皮炎和变应性接触性皮炎将单独讨论。

●(参见“掌跖部急性湿疹(出汗不良性湿疹)”)

●(参见“成人刺激性接触性皮炎”)

                      

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: 2017-07 . | This topic last updated: 2016-12-05.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Coenraads PJ. Hand eczema. N Engl J Med 2012; 367:1829.
  2. Diepgen TL, Elsner P, Schliemann S, et al. Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges 2009; 7 Suppl 3:S1.
  3. Fowler J. Chronic hand eczema: a prevalent and challenging skin condition. Cutis 2008; 82:4.
  4. Thyssen JP, Johansen JD, Linneberg A, Menné T. The epidemiology of hand eczema in the general population--prevalence and main findings. Contact Dermatitis 2010; 62:75.
  5. Mortz CG, Bindslev-Jensen C, Andersen KE. Hand eczema in The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis (TOACS): prevalence, incidence and risk factors from adolescence to adulthood. Br J Dermatol 2014; 171:313.
  6. Johannisson A, Pontén A, Svensson Å. Prevalence, incidence and predictive factors for hand eczema in young adults - a follow-up study. BMC Dermatol 2013; 13:14.
  7. Diepgen TL. Occupational skin-disease data in Europe. Int Arch Occup Environ Health 2003; 76:331.
  8. Ibler KS, Jemec GB, Flyvholm MA, et al. Hand eczema: prevalence and risk factors of hand eczema in a population of 2274 healthcare workers. Contact Dermatitis 2012; 67:200.
  9. Luk NM, Lee HC, Luk CK, et al. Hand eczema among Hong Kong nurses: a self-report questionnaire survey conducted in a regional hospital. Contact Dermatitis 2011; 65:329.
  10. Lysdal SH, Søsted H, Andersen KE, Johansen JD. Hand eczema in hairdressers: a Danish register-based study of the prevalence of hand eczema and its career consequences. Contact Dermatitis 2011; 65:151.
  11. Lysdal SH, Søsted H, Johansen JD. Do hairdressers in Denmark have their hand eczema reported as an occupational disease? Results from a register-based questionnaire study. Contact Dermatitis 2012; 66:72.
  12. de Jongh CM, Khrenova L, Verberk MM, et al. Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study. Br J Dermatol 2008; 159:621.
  13. Thyssen JP, Linneberg A, Ross-Hansen K, et al. Filaggrin mutations are strongly associated with contact sensitization in individuals with dermatitis. Contact Dermatitis 2013; 68:273.
  14. Fartasch M, Taeger D, Broding HC, et al. Evidence of increased skin irritation after wet work: impact of water exposure and occlusion. Contact Dermatitis 2012; 67:217.
  15. Larson E, Friedman C, Cohran J, et al. Prevalence and correlates of skin damage on the hands of nurses. Heart Lung 1997; 26:404.
  16. Uter W, Pfahlberg A, Gefeller O, Schwanitz HJ. Risk of hand dermatitis among hairdressers versus office workers. Scand J Work Environ Health 1999; 25:450.
  17. Sun CC, Guo YL, Lin RS. Occupational hand dermatitis in a tertiary referral dermatology clinic in Taipei. Contact Dermatitis 1995; 33:414.
  18. Scalone L, Cortesi PA, Mantovani LG, et al. Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy. Br J Dermatol 2015; 172:187.
  19. Menné T, Johansen JD, Sommerlund M, et al. Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema. Contact Dermatitis 2011; 65:3.
  20. Alavi A, Skotnicki S, Sussman G, Sibbald RG. Diagnosis and treatment of hand dermatitis. Adv Skin Wound Care 2012; 25:371.
  21. Agner T, Jungersted JM, Coenraads PJ, Diepgen T. Comparison of four methods for assessment of severity of hand eczema. Contact Dermatitis 2013; 69:107.
  22. Held E, Skoet R, Johansen JD, Agner T. The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter- and intraobserver reliability. Br J Dermatol 2005; 152:302.
  23. Ruzicka T, Lynde CW, Jemec GB, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158:808.
  24. Coenraads PJ, Van Der Walle H, Thestrup-Pedersen K, et al. Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol 2005; 152:296.
  25. Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 2004; 9:169.
  26. Mollerup A, Johansen JD, Thing LF. Knowledge, attitudes and behaviour in everyday life with chronic hand eczema: a qualitative study. Br J Dermatol 2013; 169:1056.
  27. Ibler KS, Jemec GB, Diepgen TL, et al. Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial. BMJ 2012; 345:e7822.
  28. van Gils RF, Boot CR, Knol DL, et al. The effectiveness of integrated care for patients with hand eczema: results of a randomized, controlled trial. Contact Dermatitis 2012; 66:197.
  29. Dulon M, Pohrt U, Skudlik C, Nienhaus A. Prevention of occupational skin disease: a workplace intervention study in geriatric nurses. Br J Dermatol 2009; 161:337.
  30. Löffler H, Kampf G, Schmermund D, Maibach HI. How irritant is alcohol? Br J Dermatol 2007; 157:74.
  31. Kampf G, Löffler H. Prevention of irritant contact dermatitis among health care workers by using evidence-based hand hygiene practices: a review. Ind Health 2007; 45:645.
  32. Estlander T, Jolanki R, Kanerva L. Protective Gloves. In: Hand Eczema, Menné T, Maibach HI (Eds), CRC, Boca Raton 1994.
  33. Lodén M, Wirén K, Smerud K, et al. Treatment with a barrier-strengthening moisturizer prevents relapse of hand-eczema. An open, randomized, prospective, parallel group study. Acta Derm Venereol 2010; 90:602.
  34. Draelos ZD. New treatments for restoring impaired epidermal barrier permeability: skin barrier repair creams. Clin Dermatol 2012; 30:345.
  35. Teichmann A, Jacobi U, Waibler E, et al. An in vivo model to evaluate the efficacy of barrier creams on the level of skin penetration of chemicals. Contact Dermatitis 2006; 54:5.
  36. Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol 1999; 140:882.
  37. Schliemann S, Kelterer D, Bauer A, et al. Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Contact Dermatitis 2008; 58:299.
  38. Katsarou A, Makris M, Papagiannaki K, et al. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. Eur J Dermatol 2012; 22:192.
  39. Hordinsky M, Fleischer A, Rivers JK, et al. Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized, double-blind trial. Dermatology 2010; 221:71.
  40. Bissonnette R, Diepgen TL, Elsner P, et al. Redefining treatment options in chronic hand eczema (CHE). J Eur Acad Dermatol Venereol 2010; 24 Suppl 3:1.
  41. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol 1996; 76:371.
  42. Sezer E, Etikan I. Local narrowband UVB phototherapy vs. local PUVA in the treatment of chronic hand eczema. Photodermatol Photoimmunol Photomed 2007; 23:10.
  43. Schempp CM, Müller H, Czech W, et al. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol 1997; 36:733.
  44. Tegner E, Thelin I. PUVA treatment of chronic eczematous dermatitis of the palms and soles. Acta Derm Venereol 1985; 65:451.
  45. Anveden I, Wrangsjö K, Järvholm B, Meding B. Self-reported skin exposure -- a population-based study. Contact Dermatitis 2006; 54:272.
  46. Meding B, Swanbeck G. Epidemiology of different types of hand eczema in an industrial city. Acta Derm Venereol 1989; 69:227.
  47. Brans R, Skudlik C, Weisshaar E, et al. Association between tobacco smoking and prognosis of occupational hand eczema: a prospective cohort study. Br J Dermatol 2014; 171:1108.
  48. Mollerup A, Veien NK, Johansen JD. Chronic hand eczema--self-management and prognosis: a study protocol for a randomised clinical trial. BMC Dermatol 2012; 12:6.
  49. Veien NK, Hattel T, Laurberg G. Hand eczema: causes, course, and prognosis I. Contact Dermatitis 2008; 58:330.
  50. Meding B, Wrangsjö K, Järvholm B. Fifteen-year follow-up of hand eczema: persistence and consequences. Br J Dermatol 2005; 152:975.
  51. Cvetkovski RS, Zachariae R, Jensen H, et al. Quality of life and depression in a population of occupational hand eczema patients. Contact Dermatitis 2006; 54:106.
  52. Petersen AH, Johansen JD, Hald M. Hand eczema—prognosis and consequences: a 7-year follow-up study. Br J Dermatol 2014; 171:1428.